
- The scale and consequences of cardiovascular disease reinforce why innovation in this space remains essential.
- The prevalence of cardiovascular risk factors illustrates the scale of the issue.
- Cardio Diagnostics is addressing this need through its proprietary platform, which combines artificial intelligence with multi-omic biomarker analysis.
Cardiovascular disease continues to place a profound burden on individuals, economies and healthcare systems worldwide, affecting millions of lives while driving substantial medical costs and resource demands. Cardio Diagnostics Holdings (NASDAQ: CDIO) is committed to reducing the impact of heart disease by developing a platform that integrates artificial intelligence and epigenetic and genetic biomarkers to deliver personalized cardiovascular insights from a simple blood sample, positioning itself at the intersection of precision medicine and preventive care.
Questions around this news
How does Cardio Diagnostics’ platform provide cardiovascular insights?
The release says the platform combines artificial intelligence with genetic and epigenetic biomarker analysis. It is designed to use information from a blood sample to provide personalized cardiovascular insights. The release does not describe the platform’s specific analytical methods or explain how its insights are used in clinical decisions.
What kinds of biomarkers does the company’s platform analyze?
The release identifies genetic and epigenetic biomarkers as inputs to the platform’s analysis. Genetic biomarkers relate to information in DNA, while epigenetic biomarkers relate to changes that affect how genes are regulated. The company says it combines these signals with artificial intelligence to develop personalized cardiovascular insights from a blood sample.
What does precision medicine mean in cardiovascular care?
Precision medicine aims to tailor health assessment or care to characteristics of an individual, rather than relying only on a one-size-fits-all approach. Depending on the setting, those characteristics may include biological markers, health history, or other patient information. The release describes the company’s work as being at the intersection of precision medicine and preventive care.
What is multi-omic analysis?
Multi-omic analysis examines multiple types of biological information together. For example, an analysis may combine information related to genes with other molecular signals, helping researchers study how different biological processes relate to health. The term describes an approach to analysis; the specific data types and methods can vary by application.
The scale and consequences of cardiovascular disease reinforce why innovation in this space remains essential. According to the Centers for Disease Control and Prevention (“CDC”), heart disease is the leading cause of death in the United States, accounting for approximately one in every…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]
Terms explained
- Epigenetic biomarkers
- Biological indicators related to changes that influence how genes are switched on or off, without changing the underlying DNA sequence.
- Genetic biomarkers
- Measurable features of DNA that may provide information about biological traits or health-related processes.
- Multi-omic analysis
- An approach that studies multiple kinds of biological data together, such as genetic information and other molecular signals.
- Precision medicine
- An approach to health care that uses information about an individual to help guide assessment or care.
- Preventive care
- Health services intended to help prevent illness or identify health concerns before they become more serious.
- Artificial intelligence
- Computer systems and methods that perform tasks involving abilities such as recognizing patterns, analyzing information, or generating outputs.